Vaiomer
Pre-clinicalVaiomer is the pioneer of blood microbiome, tissue microbiome exploration and leader in low bacterial biomass sample analysis.
Market Cap
Private
Pipeline
—
Patents
—
Publications
—
Private Company
Total funding raised: $26M
About
Vaiomer is the pioneer of blood microbiome, tissue microbiome exploration and leader in low bacterial biomass sample analysis.
Genetics & GenomicsMicrobiome
Funding History
3Total raised:$26M
Series B$15MJun 15, 2021
Series A$8.5MJun 15, 2018
Seed$2.5MJun 15, 2015